Showing results (351-360 of 641) with videos related to
Sort By:
Pageof 65
Pediatric Blood & Cancer|September 29, 2009
Juvenile xanthogranuloma in a child with previously unsuspected neurofibromatosis type 1 and juvenile myelomonocytic leukemiaMargarita Raygada, Diane C Arthur, Alan S Wayne, et al.Proceedings of the National Academy of Sciences of the United States of America|April 18, 2012
Immunotoxin resistance via reversible methylation of the DPH4 promoter is a unique survival strategyHui Wei, Laiman Xiang, Alan S Wayne, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2016
Influence of Cranial Radiotherapy on Outcome in Children With Acute Lymphoblastic Leukemia Treated With Contemporary TherapyAjay Vora, Anita Andreano, Ching-Hon Pui, et al.Leukemia|April 19, 2023
Preclinical pharmacokinetic and pharmacodynamic evaluation of dasatinib and ponatinib for the treatment of T-cell acute lymphoblastic leukemiaSatoshi Yoshimura, John C Panetta, Jianzhong Hu, et al.Blood|August 19, 2006
Body mass index does not influence pharmacokinetics or outcome of treatment in children with acute lymphoblastic leukemiaNobuko Hijiya, John C Panetta, Yinmei Zhou, et al.Cancer|January 19, 2012
Resumption of high-dose methotrexate after acute kidney injury and glucarpidase use in pediatric oncology patientsAnthony M Christensen, Jennifer L Pauley, Alejandro R Molinelli, et al.Plos One|August 8, 2015
Antileukemic Efficacy of Continuous vs Discontinuous Dexamethasone in Murine Models of Acute Lymphoblastic LeukemiaLaura B Ramsey, Laura J Janke, Monique A Payton, et al.Cancer|June 1, 2012
Effect of body mass index on the outcome of children with acute myeloid leukemiaHiroto Inaba, Harriet C Surprise, Stanley Pounds, et al.Nature|April 15, 2008
BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of IkarosCharles G Mullighan, Christopher B Miller, Ina Radtke, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2015
Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemiaJun J Yang, Wendy Landier, Wenjian Yang, et al.Pageof 65